FBRX
Forte Biosciences Inc

2,980
Mkt Cap
$378.56M
Volume
150,362.00
52W High
$35.62
52W Low
$4.90
PE Ratio
-6.80
FBRX Fundamentals
Price
$30.22
Prev Close
$29.26
Open
$29.23
50D MA
$29.12
Beta
0.62
Avg. Volume
226,307.70
EPS (Annual)
-$12.17
P/B
4.50
Rev/Employee
$0.00
$7.85
Loading...
Loading...
News
all
press releases
Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know
Forte Biosciences (FBRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX)
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of some unusual options trading on Wednesday. Investors acquired 30,205 call options on the stock. This represents an...
MarketBeat·10d ago
News Placeholder
Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Large Decrease in Short Interest
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 30th, there was short interest totaling...
MarketBeat·12d ago
News Placeholder
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced it will be presenting at...
Business Wire·20d ago
News Placeholder
Short Interest in Forte Biosciences, Inc. (NASDAQ:FBRX) Expands By 55.5%
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totaling 795,862 shares, an...
MarketBeat·29d ago
News Placeholder
Federated Hermes Inc. Acquires 563,147 Shares of Forte Biosciences, Inc. $FBRX
Federated Hermes Inc. boosted its holdings in Forte Biosciences, Inc. (NASDAQ:FBRX - Free Report) by 52.5% in the third quarter, according to the company in its most recent 13F filing with the SEC...
MarketBeat·29d ago
News Placeholder
Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX)
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the target of unusually large options trading activity on Wednesday. Stock traders purchased 30,205 call options on the stock. This is an...
MarketBeat·1mo ago
News Placeholder
Stock Traders Buy Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX)
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 30,205 call options on the stock. This is an increase of...
MarketBeat·2mo ago
News Placeholder
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic...
Business Wire·2mo ago
News Placeholder
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Brokerages
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five research firms that are presently covering the firm, MarketBeat reports. One...
MarketBeat·2mo ago
<
1
2
...
>

Latest FBRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.